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Abstract
In this issue of BMC Medical Genomics Griffin et al. present a user-friendly and freely accessible HIV-associated
neurocognitive disorder (HAND) genomic database that compiles viral (HIV-1) genetic sequences and other relevant
clinical and treatment data. We discuss the benefits and caveats of public data sharing in NeuroAIDS research, while
emphasizing the importance of such novel initiatives for advancing knowledge.
Commentary
Novel research initiatives are needed to alleviate and hope-
fully eventually cure complex diseases such as HIV-
associated neurocognitive disorder (HAND). The paper by
Griffin et al. [1] in this issue of BMC Medical Genomics is
an example of one such initiative. The authors have devel-
oped a HAND genomic database that compiles viral
(HIV-1) genetic sequences with information on HAND
and other relevant clinical and treatment data (previously
collected by a number of investigators who agreed to have
the viral sequences compiled). Together with American
and Chinese collaborators, the authors of the database
developed a user-friendly system that can be utilized by
other researchers and further developed. The development
stage has not been clearly outlined in this first publication,
but the database authors are contactable via the database
webpage (http://www.handdatabase.org). And it is ex-
pected that as the database evolves new requirements will
be developed similarly to already existing HIV database
which however do not collect information on HAND [2].
The authors have clearly described their quality control
protocol for accuracy of the genetic data. It is assumed
that any novel sequences will undergo the same process.
They have also used a database interface that is widely
accessible (MySQL (v.5.6.17)), similar to other HIV genetic
databases [3].
The benefits of such an initiative are immediate: because
this is a public data sharing system, of which I along with
many other scientists am a strong advocate [4], almost
instant inception of new projects is possible. And as
noted by the authors the system will foster studies on
relatively neglected parts of the HIV-1 genome that are
relevant to HIV-1 neuropathogenesis. A further benefit
is the increased statistical power that has become a
necessary condition for robust genetic analyses allowing
the required cross-validation sampling strategy. A freely
accessible database will facilitate a better representation
of the global HIV epidemic with further potential data
addition from researchers in resource-limited settings
who are otherwise often indirectly excluded due to
financial restrictions.
One important caveat not mentioned in the paper
(probably because it was beyond its scope) is the issue of
international variability in policies around data sharing
[5]. Because HAND and related information are included,
I would expect from my own research experience that
each investigator wanting to add data to this database will
have to obtain ethics approval from their respective insti-
tutions. Public data sharing is increasingly common and
many universities now seek to facilitate it. But this does
not mean that complex standardization issues are resolved
[5] especially in the case of a disorder that alters cognitive
functioning as its primary endpoint and the need to
harmonize data collection for each disease phenotype.
Perhaps for the time being the current database devel-
opers should specify what security measures have been
put in place for the database and whether or not they have
a long-term funding horizon, as has been advocated for
“omics sharing” [4].
Finally, the authors might include a more refined phe-
notyping of HAND and in particular one that matches
the current diagnostic criteria in any future development
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of the database [6]. Other information relating to HIV
or comorbid brain insult would also be needed, as well
as environmental information that is known to impact
HAND prevalence and incidence (such as education
level) [7]. This may be the occasion for extending collab-
orations, which may lead for example to new genetic
epidemiology research that tackles the complex issue of
gene-environment interactions in the development of
HAND.
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